Basic Information
venlafaxine hydrochloride
16714-043
Regulatory Information
16714-043
ANDA090174
C73584
June 20, 2023
USA
These highlights do not include all the information needed to use VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES.VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE capsules, for oral useInitial U.S. Approval: 1997
HUMAN PRESCRIPTION DRUG LABEL
3
Company Information
830546433
Active Ingredients
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
CETOSTEARYL ALCOHOL
Code: 2DMT128M1S
Class Code: IACT
GELATIN
Code: 2G86QN327L
Class Code: IACT
HYPROMELLOSES
Code: 3NXW29V3WO
Class Code: IACT
CELLULOSE, MICROCRYSTALLINE
Code: OP1R32D61U
Class Code: IACT
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 750000 MW)
Code: P2OM2Q86BI
Class Code: IACT
SODIUM LAURYL SULFATE
Code: 368GB5141J
Class Code: IACT
TALC
Code: 7SEV7J4R1U
Class Code: IACT
TITANIUM DIOXIDE
Code: 15FIX9V2JP
Class Code: IACT
FERROSOFERRIC OXIDE
Code: XM0M87F357
Class Code: IACT
Active Moieties
VENLAFAXINE
Code: GRZ5RCB1QG